eGene and Gene Company, Ltd. Enter into Three Year Distribution Relationship in China and Are Projected to Have High Volume System Sales.IRVINE, Calif. -- eGene Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :EGEI), developer of a revolutionary high-performance genetic analysis technology, announced today that it has entered into a three year distribution agreement with Gene Company, Ltd. to promote and sell eGene's HDA-GT12 system in China. Dr. Ming S. Liu, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of eGene, noted: "We are very pleased to work with Gene Company. Both companies have seen exciting business opportunities for the HDA-GT12 genetic analyzer in China, and eGene believes that Gene Company's expertise is well-suited to our product. We have trained their sales team and, based on the large market, are confident to sell high volumes of systems and consumables in the great China area in the next three years." About Gene Company, Ltd. Gene Company Limited (Gene Company) - the distribution arm of the Gene Group Holdings Limited, commenced its service to the research community in 1992. Over the years of development, Gene Company has built its brand in the market and established a solid and highly loyal customer base, constituting renowned institutions and national laboratories. In the P. R. China, Gene Company has established good connections with customers in research institutes, hospitals, and industrial plants and also successfully become one of the major research product suppliers to major genomics, proteomics, biochip biochip Small-scale device, analogous to an integrated circuit, constructed of or used to analyze organic molecules associated with living organisms. One type of theoretical biochip is a small device constructed of large organic molecules, such as proteins, and capable of and stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. research centers. With its headquarters situated in Hong Kong, Gene Company has established a sizable distribution network covering major cities in P. R. China through a wholly owned Foreign Invested Commercial Enterprise company (FICE fice n. Chiefly Southern U.S. Variant of feist. Noun 1. fice - a nervous belligerent little mongrel dog feist cur, mutt, mongrel - an inferior dog or one of mixed breed ) and collaborative alliances with local partners. Combined with almost 400 staff members and an integrated network comprised of branches/offices in Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Huhhot, Jinan, Kunming, Nanjing, Qingdao, Shanghai, Shenyang, Tianjin, Wuhan, Xian & Zhengzhou, Gene Company is the best support of advanced biotech research products. About eGene Inc. eGene Inc. (www.egeneinc.com) focuses its core technologies of capillary electrophoresis, microfluidics, liquid handling and automation to develop and manufacture low-cost microfluidic, miniaturized digital genetic analyzer systems, software and consumables for biological materials testing applications. These products detect, quantify, identify and characterize DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. and RNA RNA: see nucleic acid. RNA in full ribonucleic acid One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic at high rates of specificity and sensitivity while automating routine and non-routine laboratory and industrial procedures critical to product safety, development quality and productivity. This press release contains forward-looking statements within the meaning of the "safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such statements are made based on management's current expectations and beliefs. Actual results may vary from those currently anticipated based upon a number of factors. The company undertakes no obligation to release publicly any revision, which may be made to reflect events or circumstances after the date hereof. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion